The usual suspects are already positioning retail to not expect a big pharma cash injection until at least Flaskworks validation. So keep an eye for another carrot!
Im not the spokesperson of other longs you will have to discuss that with them. I just told you what I think and that is that if management has not realized an investment on condition of UK approval then they are even more worthless than they already have demonstrated so far to be